AFL · 10-Q · 2026Q2 · Full report
Aflac Japan Sales Trends
AFLAC INC · 2026-08-07 · Importance 25 · Surprise 48 · Matches filing data
Aflac Japan’s new annualized premium sales decreased 14.3% in yen terms in the second quarter of 2026, primarily because the prior-year period benefited from the March 2025 launch of Miraito cancer insurance. For the first six months, sales increased 23.2% in yen terms, driven by strong demand for the refreshed Tsumitasu savings-type life insurance product and Anshin Palette medical insurance, launched in December 2025. Cancer products remained the largest contributor, representing 54.7% of six-month sales, while Tsumitasu contributed 19.2% and medical and other health products contributed 20.5%. Aflac expects continued demand for third-sector cancer and medical products as pressure on Japan’s health care system increases, while first-sector products may support younger-customer acquisition and cross-selling.
Key facts
- Annualized premiums in force translated into U.S. dollars were $7.2 billion at June 30, 2026, compared with $8.2 billion at June 30, 2025. source
- For the three-month period ended June 30, 2026, Aflac Japan net earned premiums decreased primarily due to approximately ¥4 billion related to an external reinsurance transaction established in the first quarter of 2026 and approximately ¥3 billion from limited-pay products reaching premium paid-up status. source
- Strong growth in the refreshed Tsumitasu savings-type life insurance product and Anshin Palette (new medical product launched in December 2025) partially offset the sales decrease in Q2 2026. source
- The decrease in new annualized premium sales on a Japanese yen basis in the second quarter of 2026 primarily reflects a high prior-year sales baseline for Miraito cancer insurance following its launch in March 2025. source
- The increase in new annualized premium sales on a Japanese yen basis in the first six months of 2026 was driven primarily by strong sales of Tsumitasu and Anshin Palette. source
- Annualized premiums in force decreased 2.7% to ¥1.16 trillion as of June 30, 2026, compared with ¥1.19 trillion as of June 30, 2025. source
- Aflac Japan new annualized premium sales (yen basis) for the three months ended June 30, 2026 were ¥19.6 and ¥20.7 and for the six months ended June 30, 2026 were ¥37.3 and ¥34.8 (table shows these four yen values). source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | realized | -24.3% | Annualized premiums in force translated into U.S. dollars were $7.2 billion at June 30, 2026, compared with $8.2 billion at June 30, 2025. |